Partner Jamie Guerrero was quoted in a Compliance Week article, “Shooting the Messenger: Is FedEx Liable for the Contents of Deliveries?” on September 9, 2014. The article discusses the Department of Justice indicting FedEx for distributing controlled substances and prescription drugs for illegal Internet pharmacies and FedEx’s intent to fight the charges. Guerrero discussed potential options for FedEx and was quoted saying, “It’s just an example of what happens when the government feels that they’re not being taken seriously.” He also shared insights on the case and mentioned that when a company receives a subpoena from the government, “the first step is to conduct an internal investigation.”
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”